Breaking the Cycle: The Role of Microbiota-Based Biotherapies in the Reduction of Recurrent Clostridioides difficile
Breaking the Cycle: The Role of Microbiota-Based Biotherapies in the Reduction of Recurrent Clostridioides difficile
Symposium Highlights
Drs. Paul Feuerstadt, Sahil Khanna, Teena Chopra and Caterina Oneto convened at annual gastroenterology and infectious disease congresses to discuss clinical scenarios and best practices to manage recurrent Clostridioides difficile (C. difficile) infections; this activity chronicles their discussions. Tune in for updates on risk factors and prevention strategies for recurrent infection, as well as up-and-coming treatment options such as cutting-edge microbiota restoration therapies as discussed through a series of real-world patient cases.
Faculty: Paul Feuerstadt, MD, FACG, AGAF; Sahil Khanna, MBBS, MS, FACG; Teena Chopra, MD, MPH, FACP, FIDSA, FSHEA; Caterina Oneto, MD
Release Date:
Expiration Date: November 30, 2023
CME/CE is no longer available for this activity
